Oral Iopamidol in Multidetector Computed Tomography-Module 2
Oral Iopamidol in Multidetector Computed Tomography-Module 2
On-Demand Webcast
Presenter
Greg Zobel, BS, RT(R) (CT)
Team Leader, CT
St Francis Hospitals and Health Services
Adjunct Lecturer, Indiana School of Medicine
Indianapolis, Indiana
Target Audience
This activity is designed for Radiologists, Radiology Nurses, and Radiology Technologists.
Learning Objectives
After completing this activity, participants should be able to:
- Apply the experiences of single center experiences within your own practice about the effectiveness of Oral Iopamidol in MDCT
- Discuss the patient selection criteria for use of Oral Iopamidol in MDCT
- Describe the benefits and limitations of Oral Iopamidol vs. intravenous Contrast in patients undergoing MDCT
Activity Overview
This on-demand audio webcast is available with synchronized slides and audio.
To be eligible for documentation of credit, participant must participate in the full activity, complete the post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.
There is no fee associated with this activity.
Release Date: December 21, 2009
Expiration Date: January 31, 2014
Date of Last Review: December 12, 2011
Estimated time to complete: 1 hour
For questions regarding this activity, please contact 609-371-1137
Hardware/Software Requirements
All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
CME Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
This continuing nursing education activity was approved for 1 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1 contact hour.
AHRA Accreditation
Approved for 0.5 Category A, ARRT continuing education credit(s).
Independent Clinical Reviewers:
Michael Wholey, MD, MBA
Dept of Cardiovascular and Interventional Radiology
University of Texas Health Science Center at San Antonio
San Antonio, Texas
Robert S. Dieter, M.D., R.V.T.
REEE, LLC
Planning Committee
The planning committee comprises Farnoosh Sokhandon, MD, Michael Wholey, MD, MBA, Greg Zobel, BS, RT (R), (CT), and Robert Dieter, MD, R.V.T.; Alex Slonim, Lindsay Mazzagatti and Patricia Levy, NACCME
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Sokhandon has disclosed that she has no relevant financial relationships with any commercial interests.
Mr. Zobel has disclosed that he has no relevant financial relationships with any commercial interests.
Clinical Reviewers: Dr. Wholey and Dr. Dieter have disclosed that they have no relevant financial relationships with any commercial interests.
Mr. Slonim, Ms. Mazzagatti and Ms. Levy have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: The use of oral Iopamidol in multidetector computed tomography.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.
Grant Support
Supported by an educational grant from Bracco Diagnostics, Inc
